Taken together, these studies demonstrate that MCL-1 downregulation is both necessary and sufficient to induce apoptosis with selumetinib, and strongly argues that MCL-1 is a singular target that is cooperatively modulated by the combination to induce apoptosis in BRAF mutant uveal melanoma. This evidence concerns the gene BRAF and uveal melanoma.